The Emerging Role of Cancer-Associated Fibroblasts in Hematological Malignancies: From Their Influence on Tumor Progression and Drug Resistance to Novel Therapeutic Opportunities

The authors discuss the current understanding of cancer-associated fibroblasts’ pro- or anti-tumor functions in various hematological malignancies, including acute and chronic leukemia, lymphoma, and multiple myeloma.